U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. House of Webster, Inc - 492699 - 04/19/2017
  1. Warning Letters

CLOSEOUT LETTER

House of Webster, Inc MARCS-CMS 492699 —

Recipient:
House of Webster, Inc

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

 
 
Dallas District Office
4040 N. Central Expressway, Suite 300
Dallas, Texas 75204 

April 19, 2017

UPS Overnight

John Griffin, President
House of Webster, Inc.
111 South Cherokee Street
Muskogee, Oklahoma 74403

Dear Mr. Griffin:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (2016-DAL-WL-21, May 3, 2016). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,

/S/
John W. Diehl
Acting Director, Compliance Branch
Dallas District 

Cc:

Ryan T. Funa, General Manager
House of Webster, Inc.
1013 North 2nd Street
Rogers, Arkansas 72756

Back to Top